Skip to content
Clinical Trials – home

Beclomethasone Dipropionate: A Comprehensive Guide for Patients

4 / 6
trials open to patients / all trials
13+
Countries

In short

This article examines the use of Beclomethasone Dipropionate (BDP) in clinical trials for treating asthma and other respiratory conditions. BDP is an inhaled corticosteroid medication that helps reduce inflammation in the airways. We'll look at studies testing different formulations, dosages, and applications of BDP to better understand its efficacy and safety profile in both adults and children with respiratory issues.

At a glance

Drug Name
Beclomethasone Dipropionate (BDP)
Drug Type
Inhaled corticosteroid
Primary Use
Treatment of asthma and other respiratory conditions
Delivery Methods
Metered-dose inhalers (MDIs), breath-actuated inhalers (BAIs), nebulizers
Dosage Forms
Various strengths (e.g., 40 mcg, 80 mcg, 100 mcg per actuation)
Treatment Regimens
Daily maintenance, rescue medication, or combination of both
Patient Populations
Adults and children with asthma or recurrent wheezing
Key Outcome Measures
Lung function, asthma exacerbations, quality of life, asthma control
Safety Considerations
Effects on HPA axis, growth in children, local side effects

What is Beclomethasone Dipropionate?

Beclomethasone Dipropionate is a medication that belongs to a class of drugs called corticosteroids. It is commonly used to treat various respiratory conditions, particularly asthma. This medication is also known by several other names, including: BDP QVAR® Beclomethasone 17,21-dipropionate These alternative names may appear on your prescription or medication packaging.

Uses and Conditions Treated

Beclomethasone Dipropionate is primarily used to treat: Asthma: It is commonly prescribed for both adults and children with asthma, particularly those with mild persistent asthma. Bronchopulmonary Dysplasia: This is a condition that affects premature infants and can cause breathing difficulties. Ulcerative Proctosigmoiditis: In some cases, it may be used to treat this inflammatory bowel condition. The medication helps to control symptoms and prevent asthma attacks, allowing patients to lead normal, active lives.

How It Works

Beclomethasone Dipropionate works by reducing inflammation in the airways. When you inhale the medication, it coats the inside of your airways and helps to: Decrease swelling and irritation Reduce mucus production Relax the muscles around the airways These effects make it easier to breathe and help prevent asthma symptoms from occurring.

Administration Methods

Beclomethasone Dipropionate can be administered in several ways: Metered Dose Inhaler (MDI): A handheld device that delivers a precise amount of medication when you press down on the canister. Breath-Actuated Inhaler (BAI): Similar to an MDI, but it releases the medication when you inhale, making it easier to use. Dry Powder Inhaler (DPI): A device that delivers the medication in a dry powder form when you inhale deeply. Suppositories: In some cases, the medication may be administered rectally for conditions like ulcerative proctosigmoiditis. Your doctor will prescribe the most appropriate method based on your condition and personal needs.

Dosage and Frequency

The dosage and frequency of Beclomethasone Dipropionate can vary depending on several factors, including: The severity of your condition Your age The specific formulation being used For asthma treatment, common dosages include: 40 mcg to 80 mcg per puff, taken twice daily 100 mcg to 200 mcg per puff, taken twice daily It's crucial to follow your doctor's instructions precisely and not to adjust your dosage without consulting them first.

Effectiveness and Benefits

Beclomethasone Dipropionate has been shown to be effective in: Improving lung function Reducing the frequency and severity of asthma symptoms Decreasing the need for rescue medications Improving quality of life for asthma patients Regular use of this medication as prescribed can help you maintain better control over your asthma and reduce the risk of severe asthma attacks.

Safety and Side Effects

Beclomethasone Dipropionate is generally considered safe when used as directed. However, like all medications, it can cause side effects. Some potential side effects include: Throat irritation or hoarseness Oral thrush (a fungal infection in the mouth) Coughing In rare cases, inhaled corticosteroids may affect growth in children or impact the body's ability to produce natural steroids. Your doctor will monitor for these effects during treatment.

Ongoing Research

Researchers continue to study Beclomethasone Dipropionate to improve its effectiveness and understand its long-term effects. Current areas of research include: Comparing different dosing regimens to find the most effective approach Investigating its use in treating bronchopulmonary dysplasia in premature infants Studying the effects of combining Beclomethasone Dipropionate with other medications These ongoing studies aim to improve treatment options and outcomes for patients with respiratory conditions.

Questions people often ask

Conditions where Beclometasone Dipropionate is being studied

Each condition opens its own overview and trial list

Trials with Beclometasone Dipropionate

Recruiting trials first

See all 6 →
Quick filters
  • Participants:Adults
  • Participants:Children
  • Participants:Adults
  • Participants:Adults · Healthy volunteers
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).